Literature DB >> 16314945

3-Tesla intraoperative MR imaging for neurosurgery.

Walter A Hall1, Walter Galicich, Thomas Bergman, Charles L Truwit.   

Abstract

Intraoperative magnetic resonance (MR) image-guided neurosurgery has been performed since 1994. Using a 1.5-Tesla (T) intraoperative MR imaging system, we have performed more than 750 interventional procedures. Having validated the safety and efficacy of this surgical technique that is relatively amenable to nearly all new in-hospital MR suites, we sought to adapt this approach at our sister hospital where a new short-bore 3-T MR suite was being installed. Using many of the lessons learned from our initial experience at 1.5-T, we designed a new interventional suite that would enable surgery to be performed entirely within a 3-T MR environment. All surgical instrumentation including electrocautery, fiberoptic headlamp, power drill, and ultrasonic aspirator was entirely MR-compatible. A few items with limited ferromagnetism were utilized within the magnetic field under strict precaution. From 2/04 to 7/05, those cases initially performed within the 3-T surgical suite included one drainage and reservoir placement for a cystic craniopharyngioma, five brain biopsies and two craniotomies; one for open brain biopsy and another for lesion resection. The craniopharyngioma was successfully aspirated and had the reservoir catheter placed within the cyst. All five brain biopsies yielded diagnostic tissue. The craniotomy for mass resection demonstrated radiation necrosis. Although the metallic artifact from the biopsy needle was more prominent than at 1.5-T, accurate image interpretation was possible. Surgical needles, disposable scalpel, disposable razor, and surgical stapler were minimally ferromagnetic and safely controlled by the surgeon. There were no adverse events associated with any procedure. MR-guided neurosurgery can be safely and effectively performed at 3-T. The surgical environment at 3-T is comparable to that present at 1.5-T.

Entities:  

Mesh:

Year:  2005        PMID: 16314945     DOI: 10.1007/s11060-005-9046-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  7 in total

1.  A mobile high-field magnetic resonance system for neurosurgery.

Authors:  G R Sutherland; T Kaibara; D Louw; D I Hoult; B Tomanek; J Saunders
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

Review 2.  1.5 T: spectroscopy-supported brain biopsy.

Authors:  Walter A Hall; Charles L Truwit
Journal:  Neurosurg Clin N Am       Date:  2005-01       Impact factor: 2.509

3.  Intraoperative compensation for brain shift.

Authors:  C Nimsky; O Ganslandt; P Hastreiter; R Fahlbusch
Journal:  Surg Neurol       Date:  2001-12

4.  Safety, efficacy, and functionality of high-field strength interventional magnetic resonance imaging for neurosurgery.

Authors:  W A Hall; H Liu; A J Martin; C H Pozza; R E Maxwell; C L Truwit
Journal:  Neurosurgery       Date:  2000-03       Impact factor: 4.654

5.  Brain tumor resection: intraoperative monitoring with high-field-strength MR imaging-initial results.

Authors:  A J Martin; W A Hall; H Liu; C H Pozza; E Michel; S O Casey; R E Maxwell; C L Truwit
Journal:  Radiology       Date:  2000-04       Impact factor: 11.105

6.  Influence of 1.5-Tesla intraoperative MR imaging on surgical decision making.

Authors:  W A Hall; H Liu; R E Maxwell; C L Truwit
Journal:  Acta Neurochir Suppl       Date:  2003

7.  Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients.

Authors:  Christopher Nimsky; Oliver Ganslandt; Boris Von Keller; Johann Romstöck; Rudolf Fahlbusch
Journal:  Radiology       Date:  2004-08-18       Impact factor: 11.105

  7 in total
  9 in total

1.  Magnetic resonance-guided upper abdominal biopsies in a high-field wide-bore 3-T MRI system: feasibility, handling, and needle artefacts.

Authors:  Jens-Peter Kühn; Sönke Langner; Katrin Hegenscheid; Matthias Evert; Antje Kickhefel; Norbert Hosten; Ralf Puls
Journal:  Eur Radiol       Date:  2010-05-26       Impact factor: 5.315

2.  Longitudinal in vivo monitoring of rodent glioma models through thinned skull using laser speckle contrast imaging.

Authors:  Abhishek Rege; Alan C Seifert; Dan Schlattman; Yu Ouyang; Khan W Li; Luca Basaldella; Henry Brem; Betty M Tyler; Nitish V Thakor
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

Review 3.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

4.  Anaplastic astrocytoma.

Authors:  Sean A Grimm; Thomas J Pfiffner
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 5.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

6.  Implementation of a mobile 0.15-T intraoperative MR system in pediatric neuro-oncological surgery: feasibility and correlation with early postoperative high-field strength MRI.

Authors:  P L Kubben; H van Santbrink; M ter Laak-Poort; J W Weber; J S H Vles; B Granzen; J J van Overbeeke; E M J Cornips
Journal:  Childs Nerv Syst       Date:  2012-06-10       Impact factor: 1.475

7.  The role of intraoperative magnetic resonance imaging in glioma surgery.

Authors:  Danny Liang; Michael Schulder
Journal:  Surg Neurol Int       Date:  2012-10-31

Review 8.  Intraoperative MR Imaging during Glioma Resection.

Authors:  Mitsunori Matsumae; Jun Nishiyama; Kagayaki Kuroda
Journal:  Magn Reson Med Sci       Date:  2021-12-09       Impact factor: 2.760

Review 9.  Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning.

Authors:  Maria Elena Laino; Robert Young; Kathryn Beal; Sofia Haque; Yousef Mazaheri; Giuseppe Corrias; Almir Gv Bitencourt; Sasan Karimi; Sunitha B Thakur
Journal:  BJR Open       Date:  2020-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.